Some general remarks and legal restrictions in reproductive and therapeutic gene modification in Russia

The article is aimed at outlining approaches in the sphere of reproductive and therapeutic gene modification in Russia in terms of legal restrictions at the level of the studied legal prescriptions, considered also from the perspective of intellectual property. Other regulations in this sphere are considered along the way. The study is relevant as there is a number of normative prescriptions in this field that were not considered in earlier studies. Thus, the present study serves to fill in this gap. On the basis of analytical reflections on the information obtained from relevant sources and literature, the paper analyses normative prescriptions in Russia, which create patterns of biotechnological potential development and its use from the standpoint of legal restrictions in reproductive and therapeutic gene modification. The author consistently moves from the key points of one act to another in order to understand and outline approaches in this area adopted in Russia. The result of the study is the set of legal restrictions found in the current legislation. The important thing is the contribution to the improvement of the further concept of law-making policy, which should be aimed at the creation of systematic special legislation regulating the field of biotechnology and further improvement of restrictions, prohibitions and responsibilities that would not allow abuse in the form of transformation of human beings into the object of technical biomedical manipulations. The theoretical and practical significance of the results obtained is determined by the fact that foreign researchers will be provided with up-to-date scientific information on the state of Russian legislation in the field under study, which in practical terms will contribute to the understanding of the gap in the achievements of Russian and foreign researchers and practitioners in terms of their implications at the legislative level. © 2020 EManuscript Technologies. All rights reserved.